Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Epicrop Technologies
company
About
Epicrop develops a revolutionary epigenetic technology for improving crop yields.
- 11 - 50
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $216.98K
- Industries
- Agriculture,AgTech,Biotechnology,Life Science
- Founded date
- Jan 1, 2013
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Epicrop develops a revolutionary epigenetic technology for improving crop yields. It also provides support services for crop production to improve crop development and abiotic stress tolerance and is applicable to all plant species, enabling farmers to improve the crop yield while keeping the crop prices lower.Epicrop Technologies was founded in 2013 and is headquartered in Lincoln, Nebraska.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$3.41M
Epicrop Technologies has raised a total of
$3.41M
in funding over 2 rounds. Their latest funding was raised on
Mar 6, 2017 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 6, 2017 | Series A | $3.20M | 1 |
|
— | Detail |
| Jun 24, 2015 | Grant | $216.98K | 1 |
National Science Foundation
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
2
2
Epicrop Technologies is funded by 2 investors.
North Forty Ventures
and National Science Foundation
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Series A |
|
National Science Foundation
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
